Ask where the evidence stops. Leave room for an unanswered question.
In its July 2026 review, FDA found no studies that assessed epitalon’s safety in people.
Cells are the tiny living parts that make up the body.
FDA raised a possible cancer concern because epitalon may lengthen the protective caps on genetic material, which carries the instructions inside each cell.
Longer caps have been linked with a higher cancer risk.
That is a theory about risk, not a report that epitalon caused cancer in a person.
FDA also warned that epitalon given by injection could make the body’s defences attack it as if it were a germ.
The concern involves epitalon’s small chemical parts sticking together, or unwanted material being mixed in.
FDA’s review did not establish which symptoms a person might have.
Ask how the product’s contents would be checked, including whether looking at it tells you anything useful. Ask what symptoms would need medical help and whom to contact if you feel unwell.